Edwards Lifesciences Corp (EW):企業の財務・戦略的SWOT分析

◆英語タイトル:Edwards Lifesciences Corp (EW) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1300
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:62
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Edwards Lifesciences Corp (EW) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Edwards Lifesciences Corp (Edwards Lifesciences) is a medical technology company that develops, manufactures and markets devices for structural heart disease, critical care and surgical monitoring. The company’s products include surgical valve repair devices, surgical valve replacement, transcatheter heart valves, hemodynamic monitoring devices, pressure monitoring devices, and related instruments and accessories. Its products find application in various therapies, including transcatheter aortic valve replacement (TAVR), blood conservation, infection control, enhanced surgical recovery, and for the management of clotting, hypotension and sepsis. The company markets products through direct sales force and also a network of independent distributors in North America, Europe and Asia-Pacific, among others. Edwards Lifesciences is headquartered in Irvine, California, the US.

Edwards Lifesciences Corp Key Recent Developments

Mar 28,2020: Edwards pauses enrollments in pivotal mitral, tricuspid trials in response to hospitals’ focus on COVID-19
Feb 21,2020: Edwards Lifesciences’ Every Heartbeat Matters Philanthropic Initiative expanding to reach more patients
Jan 30,2020: Edwards Lifesciences reports fourth quarter results
Dec 05,2019: Edwards Lifesciences outlines growth strategy at annual investor conference 2019
Oct 23,2019: Edwards Lifesciences reports third quarter results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Edwards Lifesciences Corp – Key Facts
Edwards Lifesciences Corp – Key Employees
Edwards Lifesciences Corp – Key Employee Biographies
Edwards Lifesciences Corp – Major Products and Services
Edwards Lifesciences Corp – History
Edwards Lifesciences Corp – Company Statement
Edwards Lifesciences Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Edwards Lifesciences Corp – Business Description
Product Category: Critical Care
Overview
Performance
Product Category: Surgical Structural Heart
Overview
Performance
Product Category: Transcatheter Aortic Valve Replacement
Overview
Performance
Product Category: Transcatheter Mitral and Tricuspid Therapies
Overview
Performance
Geographical Segment: Europe
Target Markets
Performance
Geographical Segment: Japan
Performance
Geographical Segment: Rest of World
Performance
Geographical Segment: The US
Performance
R&D Overview
Edwards Lifesciences Corp – Corporate Strategy
Edwards Lifesciences Corp – SWOT Analysis
SWOT Analysis – Overview
Edwards Lifesciences Corp – Strengths
Edwards Lifesciences Corp – Weaknesses
Edwards Lifesciences Corp – Opportunities
Edwards Lifesciences Corp – Threats
Edwards Lifesciences Corp – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Edwards Lifesciences Corp, Medical Equipment, Deals By Year, 2014 to YTD 2020
Edwards Lifesciences Corp, Medical Equipment, Deals By Type, 2014 to YTD 2020
Edwards Lifesciences Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 21, 2020: Edwards Lifesciences’ Every Heartbeat Matters Philanthropic Initiative expanding to reach more patients
Jan 30, 2020: Edwards Lifesciences reports fourth quarter results
Dec 05, 2019: Edwards Lifesciences outlines growth strategy at annual investor conference 2019
Oct 23, 2019: Edwards Lifesciences reports third quarter results
Oct 10, 2019: CINDE announces Edwards Lifesciences invests $100 million to expand its operations in Costa Rica
Jul 23, 2019: Edwards Lifesciences reports second quarter results for the year 2019
Jun 21, 2019: Edwards comments on updated TAVR National Coverage Determination
Apr 23, 2019: Edwards Lifesciences announces first quarter results
Feb 13, 2019: Edwards Lifesciences to buy CASMED for $100m
Jan 31, 2019: Edwards Lifesciences reports financial results for the quarter ended December 31, 2018
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Edwards Lifesciences Corp, Key Facts
Edwards Lifesciences Corp, Key Employees
Edwards Lifesciences Corp, Key Employee Biographies
Edwards Lifesciences Corp, Major Products and Services
Edwards Lifesciences Corp, History
Edwards Lifesciences Corp, Other Locations
Edwards Lifesciences Corp, Subsidiaries
Edwards Lifesciences Corp, Key Competitors
Edwards Lifesciences Corp, Ratios based on current share price
Edwards Lifesciences Corp, Annual Ratios
Edwards Lifesciences Corp, Annual Ratios (Cont...1)
Edwards Lifesciences Corp, Annual Ratios (Cont...2)
Edwards Lifesciences Corp, Interim Ratios
Edwards Lifesciences Corp, Medical Equipment, Deals By Year, 2014 to YTD 2020
Edwards Lifesciences Corp, Medical Equipment, Deals By Type, 2014 to YTD 2020
Edwards Lifesciences Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Edwards Lifesciences Corp, Performance Chart (2015 - 2019)
Edwards Lifesciences Corp, Ratio Charts
Edwards Lifesciences Corp, Medical Equipment, Deals By Year, 2014 to YTD 2020
Edwards Lifesciences Corp, Medical Equipment, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Edwards Lifesciences Corp (EW):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ACWA Power Barka SAOG (APBS):企業の財務・戦略的SWOT分析
    ACWA Power Barka SAOG (APBS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • PetroChina Co Ltd (857):企業の財務・戦略的SWOT分析
    PetroChina Co Ltd (857) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Plains All American Pipeline LP (PAA):企業の財務・戦略的SWOT分析
    Plains All American Pipeline LP (PAA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Denka Co Ltd (4061):企業の財務・戦略的SWOT分析
    Denka Co Ltd (4061) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • The Vanguard Group, Inc.:企業の戦略的SWOT分析
    The Vanguard Group, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • PLx Pharma Inc (PLXP):製薬・医療:M&Aディール及び事業提携情報
    Summary PLx Pharma Inc (PLx Pharma) is a pharmaceutical company that develops patent-protected delivery systems. The company offers products such as PLxGuard delivery system, PLxGuard pipeline products, and PL1100 and PL1200 ibuprofen products. Its PLxGuard delivery system are used in enhancement of …
  • Northern Oil & Gas Inc (NOG):石油・ガス:M&Aディール及び事業提携情報
    Summary Northern Oil & Gas Inc (Northern) is an oil and gas company that offers acquisition, exploration and production services. The company acquires and maintains oil and natural gas properties in Bakken and Three Forks formations within the Williston Basin in North Dakota and Montana. It offers s …
  • Sainsbury’s Bank plc:企業の戦略・SWOT・財務情報
    Sainsbury's Bank plc - Strategy, SWOT and Corporate Finance Report Summary Sainsbury's Bank plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Cypark Resources Berhad (CYPARK):企業の財務・戦略的SWOT分析
    Summary Cypark Resources Berhad (CRB) is a clean technology company that offers environmental engineering services. The company offers engineering and technology services on transforming dump sites to an economic and environmental boon. Its services include environmental remediation, integrated wast …
  • Siam Food Products PCL:企業の戦略・SWOT・財務情報
    Siam Food Products PCL - Strategy, SWOT and Corporate Finance Report Summary Siam Food Products PCL - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Visa Inc:企業のM&A・事業提携・投資動向
    Visa Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Visa Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • Advicenne SA (ADVIC):製薬・医療:M&Aディール及び事業提携情報
    Summary Advicenne SA (Advicenne) is a developer of pediatric medicines. The company offers product portfolio such as ADV6209, a liquid formulation of a benzodiazepine for moderate sedation and anesthetic premedication; ADV7103, a formulation in the form of micro-tablets for renal tubulopathies. It p …
  • Dairyland Power Cooperative:企業の発電所・SWOT分析2018
    Dairyland Power Cooperative - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key e …
  • Toyota Industries Corporation:企業の戦略・SWOT・財務情報
    Toyota Industries Corporation - Strategy, SWOT and Corporate Finance Report Summary Toyota Industries Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • PZU SA:企業の戦略・SWOT・財務情報
    PZU SA - Strategy, SWOT and Corporate Finance Report Summary PZU SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Amerisafe Inc:企業の戦略・SWOT・財務分析
    Amerisafe Inc - Strategy, SWOT and Corporate Finance Report Summary Amerisafe Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Agappe Diagnostics Ltd-医療機器分野:企業M&A・提携分析
    Summary Agappe Diagnostics Ltd (Agappe) is an in-vitro diagnostic company that offers biochemistry products. The company offers biochemistry, immunochemistry, serology, coagulation, hematology, system reagents, controls and calibrators; point of care, urinalysis and auxiliary products. Its biochemis …
  • Molnlycke Health Care AB-医療機器分野:企業M&A・提携分析
    Summary Molnlycke Health Care AB (Molnlycke) a subsidiary of Investor AB, is a medical device company. The company carries out the manufacturing and marketing of single-use surgical and wound care products. The company offers a range of surgical and wound care products; infection prevention solution …
  • Olin Corporation
    Olin Corporation - Strategy, SWOT and Corporate Finance Report Summary Olin Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • OncoResponse Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary OncoResponse Inc (OncoResponse) focuses on the discovery, development and commercialization of therapeutic antibodies for the treatment of cancer. The company’s lead program includes ONCR-201, an anti-EMP2 fully-human monoclonal antibody, which is developed for female malignancies. It utiliz …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆